Background

Exclusions from the Section 301 tariffs on imports from China for 81 medical care products needed to address the COVID-19 pandemic have been extended from May 31 through Nov. 30. These exclusions are available for any product that meets the specified HTSUS numbers and product descriptions, regardless of whether the importer filed an exclusion request. 

The Office of the U.S. Trade Representative states that it may consider further extensions and/or additional modifications in the future.

In the meantime, USTR has launched a process that could result in changes to the Section 301 tariffs on other goods from China. USTR is accepting requests to continue the tariffs on List 1 goods through July 5 and will open a request period regarding List 2 goods on June 24.

ST&R is also continuing an advocacy effort to press for a full reopening of the tariff exclusion process and a renewal of any previously expired exclusions. For more information, please contact us at strdc@strtrade.com.

Click here for information on strategies importers can use to mitigate the impact of Section 301 and other tariffs.

Copyright © 2022 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.

ST&R: International Trade Law & Policy

Since 1977, we have set the standard for international trade lawyers and consultants, providing comprehensive and effective customs, import and export services to clients worldwide.

View Our Services 

Close

Cookie Consent

We have updated our Privacy Policy relating to our use of cookies on our website and the sharing of information. By continuing to use our website or subscribe to our publications, you agree to the Privacy Policy and Terms & Conditions.